More E-cigarette Stores Open As Health Debate Rages On

Is There a Biased Agenda Against the Electronic Cigarette Industry?





"I could feel the visit our website nicotine so I was constantly thinking about it, but I didn't have anything to do with my hands, you know, the whole habit of it." James said since he started vaping he has more energy, can taste food again and can breathe easier, literally and figuratively. He doesn't plan to stop at giving up tobacco, either. "The goal is to stop vaping, too," he said. v2 coupon codes giving the most effective smoking encounter., LEARN MORE AT: http://www.bakersfieldcalifornian.com/health/x1149425816/More-e-cigarette-stores-open-as-health-debate-rages-on





Content about Electronic cigarette





The results were very encouraging for the electronic cigarette industry with levels of between 2.5 mg and 3.3 mg of nicotine per cubic meter of air compared to almost 32 mg for tobacco cigarettes. It was also found that while the likes of carbon monoxide and an array of other volatile compounds associated with tobacco cigarettes were detected in the smoke, there were no detectable levels produced by electronic cigarette vapor. @ OKCIGS As we await confirmation of US electronic cigarette sales for 2013, many experts believe the US market was worth in excess of $1 billion with a worldwide market approaching $3.5 billion. save money with v2cigs discount coupon code, LEARN MORE AT: http://ivn.us/2014/01/10/biased-agenda-electronic-cigarette-industry/





Electronic Cigarettes Have a Rich and Powerful Enemy





Louis on Thursday. June 13, 2013 White Cloud Electronic Cigarettes has announced the addition of two new menthol flavors to their roster: iced berry and zero K. June 10, 2013 Electronic cigarette brand Njoy has raised $75 million in funding, the company said Monday. Understanding the Exceptional, High Quality V2 E cigarette, LEARN MORE AT: http://www.drugstorenews.com/topics/Electronic%20cigarette









Now, this will come as no surprise to some: big pharma profits from treating disease, including diseases stemming from smoking; if there is less disease to treat, then their profits will fall, which is bad news for shareholders. In addition, big pharma is highly active in the nicotine-replacement therapy, or NRT, market. NRT includes such items as nicotine gum, lozenges, and patches, and GlaxoSmithKline (NYSE: GSK ) is the leading marketer of these products within the United States. Obviously, if smokers who are in the process of quitting turn to e-cigs rather than NRT, Glaxo will lose revenue. Coupon Codes And the V2 Cigs Beginner Kits Assessment, LEARN MORE AT: http://www.fool.com/investing/general/2014/01/10/electronic-cigarettes-have-a-rich-and-powerful-ene.aspx